RA CAPITAL MANAGEMENT, L.P.
10% Owner; Director; Director, 10% Owner · 48 filings · Latest: Jun 29, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Hemab Therapeutics Holdings, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 26, 2026 | Purchase | $8.98 | 1,876 | $16.8K | 16,795,919 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 25, 2026 | Purchase | $8.88 | 31,000 | $275.3K | 16,794,043 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 17, 2026 | Sale | $0.35 | 416,911 | $145.9K | 303,719 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 16, 2026 | Purchase | $24.98 | 61,523 | $1.5M | 6,444,637 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 15, 2026 | Purchase | $24.89 | 6,146 | $153.0K | 6,383,114 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 16, 2026 | Purchase | $8.89 | 124,893 | $1.1M | 16,763,043 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 15, 2026 | Purchase | $8.99 | 15,414 | $138.6K | 16,638,150 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 12, 2026 | Purchase | $8.57 | 391,019 | $3.4M | 16,622,736 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 16, 2026 | Sale | $0.37 | 149,625 | $55.4K | 331,414 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 15, 2026 | Sale | $0.39 | 128,770 | $50.2K | 341,353 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 12, 2026 | Sale | $0.40 | 170,441 | $68.2K | 349,907 | |
PBLS | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 11, 2026 | Purchase | $20.00 | 21,188,750 | $423.8M | 2,648,278 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 11, 2026 | Sale | $0.38 | 262,503 | $99.8K | 361,229 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 10, 2026 | Sale | $0.37 | 45,923 | $17.0K | 378,666 | |
HOWL | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 9, 2026 | Sale | $0.37 | 369,800 | $136.8K | 381,717 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 11, 2026 | Purchase | $7.91 | 548,580 | $4.3M | 16,231,717 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 10, 2026 | Purchase | $7.00 | 103 | $721 | 15,683,137 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jun 9, 2026 | Purchase | $6.91 | 479,039 | $3.3M | 15,683,034 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 20, 2026 | Purchase | $24.94 | 996 | $24.8K | 6,376,968 | |
COAG | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | May 19, 2026 | Purchase | $24.97 | 3,802 | $94.9K | 6,375,972 |
Page 1 of 3
Next →